[The effect of enteral nutritional support and growth hormone on critical patients].

What Was Tested

This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

To explore the effect of early enteral nutritional support and growth hormone (GH) on critical patients.

Who Took Part

The abstract describes 34 patients taking part.

PubMed indexes the participants as adults, middle-aged adults and older adults, both men and women.

Sixty-eight critical patients were divided into enteral nutrition (EN) group and EN+GH group, with 34 patients in each group, by random number table.

How the Study Was Run

The researchers set it up as a randomized study.

The patients were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

The intake was isonitrogenous and isocaloric in both groups.

Body weight, blood biochemistry examination, nutrition state and lactulose/mannitol test were performed before and 5 days and 10 days after nutritional support.

What Was Measured

Topics PubMed links to this paper include Critical Illness, Enteral Nutrition, Human Growth Hormone and Nutritional Status.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 34 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 11 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2010 (Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue), a journal based in China.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.